Achtyes, Eric D.
Hopkins, Seth C.
Dedic, Nina
Dworak, Heather
Zeni, Courtney
Koblan, Kenneth
Funding for this research was provided by:
Sunovion
Otsuka America Pharmaceutical
Article History
Received: 18 January 2023
Accepted: 26 February 2023
First Online: 10 May 2023
Declarations
:
: Dr. Achtyes has served on advisory boards or consulted for Alkermes, Atheneum, Janssen, Karuna, Lundbeck/Otsuka, Roche, Sunovion and Teva. He has received research support from Alkermes, Astellas, Biogen, Boehringer-Ingelheim, InnateVR, Janssen, National Network of Depression Centers, Neurocrine Biosciences, Novartis, Otsuka, Pear Therapeutics, and Takeda. He serves as an advisor to CAPNOS Zero, the World Psychiatric Association and Clubhouse International, and the SMI Adviser LAI Center of Excellence (all unpaid). Drs. Hopkins, Dedic, Dworak, Zeni, and Koblan are employees of Sunovion Pharmaceuticals Inc.